Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To analyze the early events occurring during the folding and assembly of major histocompatibility complex class I antigens, we used a panel of P815 mouse mastocytoma transfectants expressing wild-type or mutant human leukocyte antigen (HLA)-Cw3 proteins. We observed that newly synthesized unassembled HLA-Cw3 heavy chains (Cw3 alpha) specifically associate with three major long-lived proteins denoted
p105
, p88 and p78, according to their size. These proteins display different kinetics of interaction. The association of
p105
is transient, while p78, which we identified as the immunoglobulin binding protein
BiP
, interacts permanently with Cw3 alpha chains. Furthermore, the binding of p88, a calnexin candidate, seems delayed compared to that of
p105
and p78. As the great majority of newly synthesized Cw3 alpha proteins expressed in P815 cells can associate with cotransfected human beta 2-microglobulin (beta 2m), our observations suggest that multiple molecular chaperones cooperate in the folding of class I heavy chains. We were unable to coimmunoprecipitate detectable levels of these proteins with oligomerized Cw3 alpha chains. However, we could still detect p78/
BiP
in transient association with mutant HLA-Cw3 heterodimers which were delayed in the endoplasmic reticulum (ER) compared to their wild-type counterparts. In this case, the dissociation of
BiP
preceded the ER to Golgi transport of these proteins. These results suggest that
BiP
release is neither related to the process of class I oligomerization nor to the ER retention of class I assembly intermediates.
...
PMID:Biogenesis of MHC class I antigens: involvement of multiple chaperone molecules. 795 6